The Efficacy of Serial Serum Amyloid A Measurements for Diagnosis and Follow-up of Necrotizing Enterocolitis in Premature Infants

Overview

Journal Pediatr Surg Int

Specialties General Surgery
Pediatrics

Date 2010 Jun 25

PMID 20574758

Citations 10

Authors

Merih Cetinkaya

Hilal Ozkan

Nilgun Koksal

Okan Akaci

Taner Ozgur

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study was to evaluate the efficacy of serial serum amyloid A (SAA) measurements in diagnosis and follow-up of necrotizing enterocolitis (NEC) in preterm infants.

Methods: A total of 144 infants were enrolled in this observational study. The infants were classified into three groups: group 1 (infants with NEC and sepsis), group 2 (infants with sepsis), and group 3 (no sepsis and NEC, control group). Data including serial whole blood count (WBC), SAA measurements that were obtained at the initial work-up of NEC and/or sepsis episode (0 day), at 24, 48 h, 7, and 10 day were evaluated. In addition, initial and serial follow-up abdominal radiographies were obtained.

Results: A total of 50 infants were diagnosed NEC. Mean SAA values (43.2 +/- 47.5 mg/dl) of infants in group 1 at 0 h were significantly higher than those in group 2 and group 3. The percentage of infants with abnormal SAA levels was significantly higher in group 1 compared with that in group 2 at 24 h. In addition, the percentage of infants with abnormal SAA levels was slightly but not statistically higher in stage 2 and stage 3 NEC group compared with that stage 1 NEC at 0, 24, 48 h. SAA levels started to decline at 48 h of onset through day 10. The cut-off value for SAA for differentiating NEC from sepsis was 23.2 mg/dl.

Conclusion: SAA may be recognized as an accurate laboratory marker in addition to clinical and radiographic findings for NEC diagnosis. It can also be used for determining the severity of NEC and response to therapy in infants with NEC.

Citing Articles

The Potential Value of Mean Platelet Volume and Platelet Distribution Width as Inflammatory Indicators in Surgical Necrotizing Enterocolitis.

Zhang Y, Chen Y, Lv J, Xiang X, Wang P, Feng W J Inflamm Res. 2024; 17:4117-4127.

PMID: 38952565 PMC: 11215663. DOI: 10.2147/JIR.S458786.

Noninvasive Fecal Cytokine and Microbiota Profiles Predict Commencement of Necrotizing Enterocolitis in a Proof-of-Concept Study.

Zenner C, Chalklen L, Adjei H, Dalby M, Mitra S, Cornwell E Gastro Hep Adv. 2023; 2(5):666-675.

PMID: 37469521 PMC: 10352139. DOI: 10.1016/j.gastha.2023.03.003.

Emerging prediction methods for early diagnosis of necrotizing enterocolitis.

Wu S, Di S, Liu T, Shi Y Front Med (Lausanne). 2022; 9:985219.

PMID: 36186788 PMC: 9523100. DOI: 10.3389/fmed.2022.985219.

Analysis of Factors Influencing Outcomes in Preterm Infants With Necrotizing Enterocolitis.

Han J, Liu G, Yu M, Li G, Cao J, Duan L Front Pediatr. 2022; 10:768107.

PMID: 35633977 PMC: 9136447. DOI: 10.3389/fped.2022.768107.

The Mean Platelet Volume Combined with Procalcitonin as an Early Accessible Marker Helps to Predict the Severity of Necrotizing Enterocolitis in Preterm Infants.

Cai N, Liao W, Chen Z, Tao M, Chen S Int J Gen Med. 2022; 15:3789-3795.

PMID: 35422655 PMC: 9004728. DOI: 10.2147/IJGM.S346665.

References

Hsueh W, Caplan M, Qu X, Tan X, De Plaen I, GONZALEZ-CRUSSI F . Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol. 2002; 6(1):6-23. PMC: 7098425. DOI: 10.1007/s10024-002-0602-z. View

Amer M, Hedlund E, Rochester J, Caplan M . Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate. 2003; 85(3):159-66. DOI: 10.1159/000075306. View

Pourcyrous M, Bada H, KORONES S, Baselski V, Wong S . Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics. 1993; 92(3):431-5. View

Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M . Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2008; 29(3):225-31. DOI: 10.1038/jp.2008.207. View

Evennett N, Alexander N, Petrov M, Pierro A, Eaton S . A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg. 2009; 44(11):2192-201. DOI: 10.1016/j.jpedsurg.2009.07.028. View

Gitto E, Karbownik M, Reiter R, Tan D, Cuzzocrea S, Chiurazzi P . Effects of melatonin treatment in septic newborns. Pediatr Res. 2001; 50(6):756-60. DOI: 10.1203/00006450-200112000-00021. View

Isaacs D, North J, Lindsell D, Wilkinson A . Serum acute phase reactants in necrotizing enterocolitis. Acta Paediatr Scand. 1987; 76(6):923-7. DOI: 10.1111/j.1651-2227.1987.tb17265.x. View

Rodwell R, Leslie A, Tudehope D . Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr. 1988; 112(5):761-7. DOI: 10.1016/s0022-3476(88)80699-1. View

Arnon S, Litmanovitz I, Regev R, Bauer S, Shainkin-Kestenbaum R, Dolfin T . Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J Perinatol. 2007; 27(5):297-302. DOI: 10.1038/sj.jp.7211682. View

10.

Hackam D, Upperman J, Grishin A, Ford H . Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2005; 14(1):49-57. DOI: 10.1053/j.sempedsurg.2004.10.025. View

11.

Fell J . Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. Early Hum Dev. 2005; 81(1):117-22. DOI: 10.1016/j.earlhumdev.2004.10.001. View

12.

Young C, Sharma R, Handfield M, Mai V, Neu J . Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?. Pediatr Res. 2009; 65(5 Pt 2):91R-97R. PMC: 2929681. DOI: 10.1203/PDR.0b013e31819dba7d. View

13.

Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340(6):448-54. DOI: 10.1056/NEJM199902113400607. View

14.

Walsh M, Kliegman R . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986; 33(1):179-201. PMC: 7131118. DOI: 10.1016/s0031-3955(16)34975-6. View

15.

Harris M, DAngio C, Gallagher P, Kaufman D, Evans J, Kilpatrick L . Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr. 2005; 147(4):462-8. DOI: 10.1016/j.jpeds.2005.04.037. View

16.

Malle E, Steinmetz A, Raynes J . Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993; 102(2):131-46. DOI: 10.1016/0021-9150(93)90155-n. View

17.

Mayer J, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A . Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg. 2002; 89(2):163-71. DOI: 10.1046/j.0007-1323.2001.01972.x. View

18.

Turner D, Hammerman C, Rudensky B, Schlesinger Y, Wine E, Muise A . Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig Dis Sci. 2007; 52(11):2972-6. DOI: 10.1007/s10620-007-9763-y. View

19.

Patole S . Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev. 2007; 83(10):635-42. DOI: 10.1016/j.earlhumdev.2007.07.007. View

20.

Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger H . Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med. 2001; 28(3):736-42. DOI: 10.1097/00003246-200003000-00022. View